子宫内膜异位症和盆腔痛腹腔镜手术后的阿片类药物使用情况
这项前瞻性调查研究纳入92例子宫内膜异位症或盆腔痛患者,在腹腔镜日间手术后28天内完成1次术前和7次术后调查。术后28天平均服用6.8片5 mg羟考酮片,平均处方10.2片;既往因盆腔痛行腹腔镜手术和子宫切除术与术后麻醉药使用显著增加相关。大多数患者术后阿片类药物需求低于处方量。
要点
- 术后28天平均服用6.8片5 mg羟考酮,平均处方10.2片,多数患者需求低于处方量。
- 既往因盆腔痛行腹腔镜手术者术后麻醉药用量显著增加(8.2 vs 5.6片;p = .044)。
- 子宫切除术是唯一与术后麻醉药用量显著增加相关的手术(9.7 vs 5.4片;p = .013)。
核心结论
- 大多数因子宫内膜异位症和盆腔痛行腹腔镜手术的患者术后阿片类药物需求低于处方量,提示外科医生可对此人群减少术后麻醉药处方。
- 既往因盆腔痛手术、自报慢性盆腔痛综合征、焦虑和抑郁的患者可能代表术后阿片类药物需求增加的一个亚组。
研究设计与样本
- 前瞻性、基于调查的研究,受试者在术后28天内完成1次术前和7次术后调查,内容涉及药物使用和疼痛控制。
- 研究在三级学术中心开展,共招募100名子宫内膜异位症或盆腔痛女性,排除8例,最终样本量为92例。
- 干预为由经过专科培训的微创妇科医生实施的腹腔镜日间出院手术。
主要发现
- 所有患者均完成术前调查,术后应答率为70.7%至80%。
- 术后28天平均服用5 mg羟考酮片数为6.8片,平均处方片数为10.2片,最少4片(n = 1),最多20片(n = 3)。
- 既往因盆腔痛行腹腔镜手术与术后麻醉药使用显著增加相关(8.2 vs 5.6;p = .044)。
- 子宫切除术是唯一与术后麻醉药使用显著增加相关的手术(9.7 vs 5.4;p = .013)。
- 深部子宫内膜异位症或病理确诊子宫内膜异位症与服药片数无差异(所有p >.36)。
临床怎么用
- 原文结论提示外科医生可对此人群减少术后麻醉药处方。
- 作者指出既往因盆腔痛手术、自报慢性盆腔痛综合征、焦虑和抑郁的患者可能代表术后阿片类药物需求增加的一个亚组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: The primary objective was to quantify postoperative opioid use after laparoscopic surgery for endometriosis or pelvic pain. The secondary objective was to identify patient characteristics associated with greater postoperative opioid requirements. DESIGN: Prospective, survey-based study in which subjects completed 1 preoperative and 7 postoperative surveys within 28 days of surgery regarding medication usage and pain control. SETTING: Tertiary care, academic center. PATIENTS: A total of 100 women with endometriosis or pelvic pain. INTERVENTIONS: Laparoscopic same-day discharge surgery by fellowship-trained minimally invasive gynecologists. MEASUREMENTS AND MAIN RESULTS: A total of 100 patients were recruited and 8 excluded, for a final sample size of 92 patients. All patients completed the preoperative survey. Postoperative response rates ranged from 70.7% to 80%. The mean number of pills (5 mg oxycodone tablets) taken by day 28 was 6.8. The average number of pills prescribed was 10.2, with a minimum of 4 (n = 1) and maximum of 20 (n = 3). Previous laparoscopy for pelvic pain was associated with a significant increase in postoperative narcotic use (8.2 vs 5.6; p = .044). Hysterectomy was the only surgical procedure associated with a significant increase in postoperative narcotic use (9.7 vs 5.4; p = .013). There were no difference in number of pills taken by presence of deep endometriosis or pathology-confirmed endometriosis (all p >.36). There was a trend of greater opioid use in patients with diagnoses of self-reported chronic pelvic pain, anxiety, and depression (7.9 vs 5.7, p = .051; 7.7 vs 5.2, p = .155; 8.1 vs 5.6, p = .118). CONCLUSION: Most patients undergoing laparoscopic surgery for endometriosis and pelvic pain had a lower postoperative opioid requirement than prescribed, suggesting surgeons can prescribe fewer postoperative narcotics in this population. Patients with a previous surgery for pelvic pain, self-reported chronic pelvic pain syndrome, anxiety, and depression may represent a subset of patients with increased postoperative opioid requirements.
引用
- Heres CK, Rindos NB, Fulcher IR, et al. Opioid Use After Laparoscopic Surgery for Endometriosis and Pelvic Pain. J Minim Invasive Gynecol. 2022. PMID: 36162768. doi:10.1016/j.jmig.2022.09.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。